B cell lymphoma vaccine - Biomira

Drug Profile

B cell lymphoma vaccine - Biomira

Alternative Names: Lymphoma vaccine - Biomira

Latest Information Update: 30 Nov 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biomira USA
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Lymphoma

Most Recent Events

  • 30 Nov 2004 Data from a media release have been added to the adverse events and Cancer therapeutic trials and immunogenicity sections
  • 13 Aug 2002 B cell lymphoma vaccine is available for licensing (http://www.biomira.com)
  • 21 Nov 2001 Discontinued - Phase-I for Lymphoma in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top